DUODART

This brand name is authorized in Austria, Australia, Cyprus, Ecuador, Spain, Finland, Hong Kong, Croatia, Israel, Nigeria, Poland, Romania, Singapore, South Africa

Active ingredients

The drug DUODART contains a combination of these active pharmaceutical ingredients (APIs):

1 Dutasteride
UNII O0J6XJN02I - DUTASTERIDE

Dutasteride reduces circulating levels of dihydrotestosterone (DHT) by inhibiting both type 1 and type 2, 5α-reductase isoenzymes which are responsible for the conversion of testosterone to DHT.

Read about Dutasteride
2 Tamsulosin
UNII 11SV1951MR - TAMSULOSIN HYDROCHLORIDE

Tamsulosin binds selectively and competitively to post-synaptic α1-adrenoreceptors, prevailingly their subtypes designated α1A and α1D. Thus relaxation of smooth muscles of the prostate and urethra is achieved, which leads to a reduction of tonus and an improvement of the urinary flow.

Read about Tamsulosin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
DUODART Capsule, hard Web Search MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G04CA52 Tamsulosin and dutasteride G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CA Alpha-adrenoreceptor antagonists
Discover more medicines within G04CA52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10102Q, 5490Y
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): H5100513
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 72275
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 080023, 080034
Country: HK Department of Health Drug Office Identifier(s): 61184
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-979570583
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6833
Country: NG Registered Drug Product Database Identifier(s): B4-3532
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100230122, 100468920
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W67754001, W67754002, W67754003
Country: SG Health Sciences Authority Identifier(s): 14181P
Country: ZA Health Products Regulatory Authority Identifier(s): 44/21.12/0850

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.